Marlborough, Mass.-based ReWalk is now able to bill Medicare directly for the procurement of its ReWalk personal exoskeleton for Medicare beneficiaries, thanks to the authorization from the Centers for Medicare & Medicaid Services (CMS), according to a news release.
In July, ReWalk received CMS healthcare common procedure coding system (HCPCS) level II code K1007 for its ReWalk 6.0 exoskeleton system, which became effective on Oct. 1, marking the first such code for an exoskeleton medical device.
With the HCPCS code in effect, ReWalk is set to pursue in-network status with private insurance companies to open access to individuals who do not have out-of-network durable medical equipment benefits and/or those with high out-of-pocket costs with out-of-network providers.
“As proud pioneers in this industry, gaining provider status is an important next step for improving access to our personal exoskeleton,” ReWalk CEO Larry Jasinski said in the release. “However, accreditation does not guarantee coverage policies, so the Company is evaluating pathways and opportunities to adjoin accreditation with provider policies to get our personal exoskeleton to more members of the spinal cord injury community.”